Cargando…

Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prostate brachytherapy

PURPOSE: The purpose of this study was to characterize benign prostate-specific antigen (PSA) bounces of at least 2.0 ng/mL and biochemical failure as defined by the Phoenix definition after prostate brachytherapy at our institution, and to investigate distinguishing features between three outcome g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hackett, Cian, Ghosh, Sunita, Sloboda, Ron, Martell, Kevin, Lan, Lanna, Pervez, Nadeem, Pedersen, John, Yee, Don, Murtha, Albert, Amanie, John, Usmani, Nawaid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2014
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200178/ https://www.ncbi.nlm.nih.gov/pubmed/25337125 http://dx.doi.org/10.5114/jcb.2014.45093

Ejemplares similares

Unexpected Seed Migration in Prostate Brachytherapy Implants Coincident with Change in Seed Stranding Product
por: Rose, Jim, et al.
Publicado: (2017)

Clinical features of prostate-specific antigen bounce after (125)I brachytherapy for prostate cancer
por: Kubo, Katsumaro, et al.
Publicado: (2018)

Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapy
por: Yamamoto, Yoichiro, et al.
Publicado: (2016)

Prostate-Specific Antigen Bounce after (125)I Brachytherapy Using Stranded Seeds with Intraoperative Optimization for Prostate Cancer
por: Kim, Tae Hyung, et al.
Publicado: (2022)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

Permanent (125)I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence
por: Mazeron, Renaud, et al.
Publicado: (2012)

Prostate-specific antigen bounce predicts for a favorable prognosis following brachytherapy: a meta-analysis
por: Bernstein, Michael B., et al.
Publicado: (2013)

Impact of edema and seed movement on the dosimetry of prostate seed implants
por: Sloboda, Ron S., et al.
Publicado: (2012)

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy
por: Lacy, John M., et al.
Publicado: (2016)

Prostate-Specific Antigen Bounce Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Vu, Charles C., et al.
Publicado: (2014)

Seminal Vesicle Treatment for Localized Prostate Cancer Treated with External Beam Radiotherapy
por: Steed, Tanner, et al.
Publicado: (2023)

Indications for additional volume studies for gland volume estimation in prostate cancer brachytherapy
por: Khanolkar, Rutvij A, et al.
Publicado: (2022)

Robotic Ultrasound Scanning With Real-Time Image-Based Force Adjustment: Quick Response for Enabling Physical Distancing During the COVID-19 Pandemic
por: Akbari, Mojtaba, et al.
Publicado: (2021)

Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer
por: Tanaka, Nobumichi, et al.
Publicado: (2012)

MRI‐TRUS registration methodology for TRUS‐guided HDR prostate brachytherapy
por: McGeachy, Philip, et al.
Publicado: (2021)

Parameters predicting for prostate specific antigen response rates at one year post low-dose-rate intraoperative prostate brachytherapy
por: Martell, Kevin, et al.
Publicado: (2017)

Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2020)

Photoacoustic imaging of prostate brachytherapy seeds
por: Su, Jimmy L., et al.
Publicado: (2011)

Prostate specific antigen bounce after intensity-modulated radiation therapy in an Asian population
por: Tan, Yu Guang, et al.
Publicado: (2016)

An evaluation of the Clarity 3D ultrasound system for prostate localization
por: Robinson, Don, et al.
Publicado: (2012)

The phylogeny of permanent prostate brachytherapy
por: Aronowitz, Jesse N., et al.
Publicado: (2013)

Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter, phase II randomized controlled trial
por: Kim, Julian O., et al.
Publicado: (2021)

Bouncing Branes
por: Burgess, C.P., et al.
Publicado: (2003)

G-Bounce
por: Easson, Damien A, et al.
Publicado: (2011)

Bouncing Back
por: Wojtys, Edward M.
Publicado: (2016)

Bounce: how to bounce back from just about anything
por: Hasson, Gill, et al.
Publicado: (2012)

Radiation-Induced Leiomyosarcoma of the Prostate after Brachytherapy for Prostatic Adenocarcinoma
por: Horiguchi, Hiroto, et al.
Publicado: (2014)

The current role of imaging for prostate brachytherapy
por: Carey, Brendan, et al.
Publicado: (2007)

Prostate brachytherapy: HDR or seed implant
por: Das, K. R.
Publicado: (2006)

Prostate cancer brachytherapy: guidelines overview
por: Wojcieszek, Piotr, et al.
Publicado: (2012)

Current Status of Brachytherapy for Prostate Cancer
por: Park, Dong Soo
Publicado: (2012)

Low dose rate prostate brachytherapy
por: Stish, Bradley J., et al.
Publicado: (2018)

Brachytherapy for oligometastatic prostate cancer to the penis
por: Martz, Nicolas, et al.
Publicado: (2021)

Utilization of prostate brachytherapy for low risk prostate cancer: Is the decline overstated?
por: Safdieh, Joseph, et al.
Publicado: (2016)

Evaluation of an automated seed loader for seed calibration in prostate brachytherapy
por: Wan, Shuying, et al.
Publicado: (2006)

Plastic ball bounces in
Publicado: (1986)

BROOKHAVEN: Bouncing neutrinos
Publicado: (1981)

How to Bounce Forward
por: Cawthorn, Sam
Publicado: (2019)

Surprising quantum bounces
por: Nesvizhevsky, Valery, et al.
Publicado: (2015)

Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?
por: Taussky, Daniel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4eobkpokurt3m5e71ebde61ekn